Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $51.4 million.

  • Healthequity's Other Operating Expenses rose 83.75% to $51.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $201.4 million, marking a year-over-year increase of 259.8%. This contributed to the annual value of $202.6 million for FY2025, which is 1777.59% up from last year.
  • As of Q4 2025, Healthequity's Other Operating Expenses stood at $51.4 million, which was up 83.75% from $46.9 million recorded in Q3 2025.
  • Healthequity's Other Operating Expenses' 5-year high stood at $53.0 million during Q2 2025, with a 5-year trough of $32.6 million in Q4 2021.
  • Over the past 5 years, Healthequity's median Other Operating Expenses value was $42.6 million (recorded in 2023), while the average stood at $43.2 million.
  • In the last 5 years, Healthequity's Other Operating Expenses skyrocketed by 2644.39% in 2022 and then tumbled by 1063.31% in 2025.
  • Healthequity's Other Operating Expenses (Quarter) stood at $32.6 million in 2021, then increased by 26.44% to $41.2 million in 2022, then increased by 3.93% to $42.9 million in 2023, then grew by 18.93% to $51.0 million in 2024, then rose by 0.84% to $51.4 million in 2025.
  • Its last three reported values are $51.4 million in Q4 2025, $46.9 million for Q3 2025, and $53.0 million during Q2 2025.